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GC-MS Gas chromatography mass spectrometry
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IFN g Interferon-g
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LAL Limulus  amebocyte lysate assay
LBP Lipopolysaccharide-binding protein
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ODTS Organic Dust Toxic Syndrome
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PBMC Peripheral blood mononuclear cells
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RANTES Factor regulated upon activation in normal T-cell, expressed and 
secreted
SD Standard deviation
SEM Standard error of the mean
Swine dust Swine confinement building dust
VC Vital capacity
TNF- a Tumor necrosis factor alpha
3-OH 3-hydroxylated
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11. Introduction
1.1. Survey of ODTS
Organic Dust Toxic Syndrome (ODTS) is a term applied to "mill fever, grain
fever, inhalation fever, humidifier fever and toxic pneumonitis". In ODTS, there is
typically an acute febrile condition, following inhalation of organic dust with
transient fever, muscle aches, chest-tightness, dyspnoea and other influenza-like
symptoms (1-3). The ODTS reaction does not require pre-sensitization.
Diagnostic chest x-ray is usually normal. The symptoms usually disappear within
24 to 48 h and there are no remaining sequelae.
The dusts associated with ODTS include swine products, hay, straw, grain,
wood chip, moldy silage and haylage, and other moldy material, mostly present in
an agricultural environment (2, 4-9)
The cumulative prevalence of ODTS is 6 - 8 % among farmers (10). The
occurrence of ODTS is more common among swine producers and grain workers,
affecting up to 30% of the exposed subjects (11, 12). These rates are 30-50 times
higher than that of allergic alveolitis (13).
Diagnosis of ODTS is usually based upon a number of factors, with an
appropriate temporal exposure history being the most important. Symptoms are
directly related to exposure levels. The syndrome is often misdiagnosed as acute
hypersensitivity pneumonitis (HP, also called extrinsic allergic alveolitis) since
symptoms are similar. HP is a pulmonary illness resulting from an immunologic
reaction against a variety of inhaled environmental antigens. There are many
differences between ODTS and HP: the chest x-ray does not show infiltrates;
severe hypoxemia does not occur; prior sensitization to antigens in the organic
dust is not required; and there are no known sequelae of physiological
significance,  such as the increased sensitivity to dust and pulmonary fibrosis. The
differences are given in table 1 (14-16).
Exact agents and mechanisms associated with ODTS are still not clear;
however, it has been suggested that the reaction can be caused by endotoxin,
fungi, bacteria and possibly other agents in the dust (3, 15, 17).
2Table 1. Similarities and differences between HP and ODTS
__________________________________________________________________
HP ODTS
__________________________________________________________________
Synonymous farmers' lung grain fever
mushroom workers' lung silo unloaders' disease
bark strippers' disease inhalation fever
Allergic alveolitis toxic pneumonitis
Exposure level low or high high
Latency 4-8 hours 4-12 hours
Symptoms fever, chills, cough, dyspnea fever, chills, cough, 
myalgias, dyspnea
Occurs in cluster No Common
Duration of illness Usually less than 24 hours 12-36 hours
White blood count Leukocytosis, neutrophilia Leukocytosis,
neutrophilia
Pulmonary function Restrictive defect may be severe Normal or mild restrictive
Chest examination Crackles Clear (rarely rhonchi)
Chest radiograph Often abnormal interstitial pattern Usually normal
Serology Usually positive Usually negative
BAL Mononuclear cells Neutrophils
Lung histology Lymphocyte and plasma cell Polymorphonuclear 
reaction, granulomas reaction predominant
Pathogenesis Hypersensitivity to fungal or Nonspecific inflammatory
bacterial antigens reaction to endotoxin
Treatment Glucocorticoids Supportive
Progressive disease Can occur None
Risk of recurrence Likely on any  exposure to Likely only after new heavy
antigen  exposure to organic dust
Prevention Absolute avoidance of exposure Dust mask, avoidance of
to causative antigen heavy exposure
__________________________________________________________________
1.2. Animal Confinement Building
Swine are usually bred in confinement buildings with many swine which generate
high dust levels. Intensive swine housing began in Europe and Sweden in the
early 1960's. The confinement building are self-contained structures that are fully
enclosed and that usually have minimally effective ventilation systems. Swine are
housed in individual pens, are fed through an automatic feeding system that
generates respirable grain dust, and stand on a slotted floor so that their urine and
faeces can collect in  manure canals, leading to manure pits outsides the building.
The pigs are therefor exposed directly manure gases like NH3, H3S and CH4 also
(18).
1.3. Swine Dust
Swine dust is a very complex substance containing components of both animal
and plant origin, as well as microbial constituents and microbial metabolites.
Animals contribute to the composition of organic dust primarily by their
shedding of skin, gut epithelium and microorganisms, or by their excretion of
3faecal waste products (19). Material of plant origin in swine dusts comes from
animal feed, and straw used as bedding material.
 In the confinement house, there are also irritating gases, such as hydrogen
sulphide, carbon dioxide, carbon monoxide, ammonia, and methane. In addition to
having direct toxic or allergenic properties, these products also serve as a
substrate for the growth of microorganisms. Airborne microorganisms in animal
houses come from several different sources, including moldy feed, bedding, the
animals themselves, and their excreta. The animals yield airborne skin scales,
which may carry bacteria, while urine and faecal material may form aerosols also
carrying Gram-negative bacteria (20-24). Microorganisms in pig houses are listed
in table 3.
Table 2. Swine dust components (25, 26).
_______________________________________________________
Swine dander
Animal hair
Urine, mites, or their parts
Bacteria
Bacterial endotoxin
(1-3) §-D-glucan in feed
Microbial protease
Pollen grains
Particles of plants
Feed grains
Hay
Silage
Fungal spores
Hyphae or sporangia from decomposing organic material
Mycotoxins
_______________________________________________________
Table 3.  Pig house microorganisms (culturable)
____________________________________________________________
Bacteria Molds Yeasts
____________________________________________________________
Aerococcus viridans Acremonium Candida
Bacillus spp Aspergillus Cryptococcus
Escherichia  coli Alternaria Hansenula
Klebsiella Circinella Rhodotorula
Micrococcus lylae Cladosporium Trichosporon
Pseudomonas Fusarium Torulopsis
Rhodococcus Geotrichum Prototheca
Staphylococcus lentus Mucor
S.hominis Paecilomyces
Xanthomonas Penicillium
Yersinia Rhizopus
Scopulariopsis brevicaulis
Stemphylium
____________________________________________________________
4Measurements of bacteria in swine houses were reported by Crook and
Kiekhaefer (22, 24). In pig houses in southern Sweden, total bacteria were 2.3 to
3.6 * 105 cfu/m3 air, Gram-negative bacteria were 6.5 to 11.0 *10 4 cfu/m3, and
fungi 95 to 410 cfu/m3. The majority of the bacteria (68 - 96%) were Gram-
positive enterococci. About 25% of Gram-negative bacteria were on particles with
an aerodynamic diameter  <5 mm (21).
1.4. Bacteria Cell Wall
The cell membrane is very  similar in both G+ and G- bacteria. The external cell
wall structure differs greatly between the two type of organisms (figure 1). G+
bacteria are distinguished by a cross-linked, large peptidoglycan at the surface,
outside the lipid cell membrane. G- bacteria have only a thin peptidoglycan wall,
but they have an additional outer cell membrane with endotoxin (LPS) on its
surface. The LPS molecule consists of lipid A (which is highly conserved and is
responsible for most of toxicity of LPS), the core of oligosaccharides (which are
also well conserved) and the outer O-antigen or the surface of the oligosccharide
(which is structurally and antigenically diverse between strains) (27, 28).
Gram-positive bacteria can cause inflammation in two ways: by secreting a
toxin (e.g superantigens, streptolysin O, S.aureus a toxin), or via servial
components of the cell wall. LPS is the primary initiator of Gram-negative
inflammation. LPS stimulates various inflammatory cells (macrophages or
polymorphonuclear) to produce cytokines, which in turn results in a cascade of
events leading to inflammation or sepsis (29, 30).
Gas chromatography mass spectrometry (GC-MS) analysis has been developed
for quantifying and characterising airborne microorganisms (31, 32). Muramic
acid (MuAc) is a chemical marker for bacterial peptidoglycan and 3-hydroxylated
fatty (3-OH fatty) acid is a marker for total LPS, which is found in lipid A, the
toxic part of the endotoxin. The GC-MS gives quantitative results and enables the
characterisation of the microbiological composition of the air filter sample (33).
1.5. Cytokines
Cytokines are a group of low-molecular weight (<80 kDa) regulatory
glycoproteins secreted by white blood cells and a variety of other cells in response
to a number of inducing stimuli. They are mediators of short range signals
between cells. Cytokines are extremely biologically active compounds acting at
concentrations as low as 10 -15 to 10 -10 mol/L in an autocrine, paracrine, or
endocrine fashion via high affinity specific receptors to stimulate target cell
functions (34).
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6Cytokines manifest an incredible array of biological effects which frequently
overlap. A key feature of many of them is their pleiotropy, redundancy, synergy
and antagonism, by which they can regulate cellular activity in a coordinated
interactive way.
 Cytokines may be roughly grouped into pro-inflammatory (i.e. IL-1, IL-6, IL-
8, IL-10, IL-12, TNF-a, TGF-§), immuno-regulatory (i.e. IL-1, IL-2, IL-4, r-IFN,
IL-6, IL-7, IL-13, IL-14), and growth and differentiation function (i.e. IL-3, IL-5,
GM-CSF).
Cytokines are also possible to classify according to structure, biological activity
and the structure of their receptor (table 4) (34, 35).
Table 4 . Structural groups of cytokines and receptors
__________________________________________________________________
Cytokine structure          Receptor class Shared chain Cytokine
__________________________________________________________________
4-a-helical short          Haemopoietin common g IL-2, IL-4, IL-7,
chain          domain IL-9, IL-13, IL-15
__________________________________________________________________
4-a-helical short          Haemopoietin common § IL-3, IL-5,
chain          domain GM-CSF
__________________________________________________________________
4-a-helical short chain           IFN-g R IFN-g
__________________________________________________________________
4-a-helical long chain            Haemopoietin domain gp130 IL-6, IL-11
__________________________________________________________________
§-sheet          serine/threonine kinase TGF§
__________________________________________________________________
§-sheet          Ig-like IL-1a, IL-1§
__________________________________________________________________
§-sheet          TNFR p75, p55 TNF-a, TNF-§
CD40L,CD27L
FASL
__________________________________________________________________
1.5.1. Inflammatory Cytokines
Inflammation is a physiologic response to a variety of stimuli. An acute
inflammatory response exhibits rapid onset and is of short duration, involving
both localized and systemic responses. The local inflammatory response is
accompanied by a systemic response known as the "acute phase response" which
is initiated by activation of tissue macrophage and the release of inflammatory
cytokines. Inflammatory cells (36) with capability to produce the cytokines IL-1,
IL-6, and TNF include monocytes-macrophages, granulocytes, B and T
-lymphocytes, endothelial cells, epithelial cells, mast cells, fibroblasts, nerve-
cells, astrocytes, synovial cells, and keratinocytes (37-39). Inflammatory
mediators are released from the inflammatory cells, causing vasodilatation (e.g.
prostaglandins and histamine) and vascular permeabilization ( e.g. leukotrienes,
prostaglandins, histamine and serotonin). The increased blood flow through the
tissue (causing redness and heat), as well as the leakage of cells and fluid
7(extravasation) into the tissue (swelling and pain). A short summary of
inflammatory cytokine is shown in table 5.
A complete discussion of cytokines can not be included in this thesis. However,
the properties of IL-1, IL-6 and TNF-a which are important and related to the
present study are presented. Those cytokines are produced in high concentrations
by monocytes and were previously called monokines. However, other types of
cells can also produce these cytokines and these cytokines are influenced by one
another (40-42). For example, IL-1 and TNF are potent inducers of IL-6, and IL-6
inversely regulates TNF expression. Although these cytokines are pleiotropic,
they are able to regulate the immune response, hematopoiesis, and inflammatory
reaction in specific manners in vivo. The action of these three cytokines is widely
overlapping (figure 2), but each show a particular characteristic function through
which it was discovered and identified (43). It is  known that these three cytokines
induce activate transcription factor e.g. NF-kB, which is a crucial signalling
intermediate in the LPS response pathway, coordinating this inflammatory
response (44, 45). The mechanism is shown in figure 3.
IL-6
IL-1 TNF- 
Antibody 
formation
Inflammation
Tumoricidal
activity and
chachexia
Immune response
hematopoiesis
   inflammatory
     reaction
     
     
a
Figure 2. Cytokine Overlapping
8Table 5. Inflammatory Cytokines, Principal Effects
___________________________________________________________
1. Interleukin-1
Antigen presentation to T-cell; Adhesion molecules; Granuloma formation; 
Lymphocyte proliferation; IL-2, IL-3, IL-6 production; Acute phase proteins; 
Fever.
2. Interleukin-6
Differentiation of T-cell; IL-2 production; IgG synthesis; Acute phase proteins; 
Fever.
3. Interleukin-8
Chemotaxis; Activate macrophages; Induces adhesion molecules.
4. Tumour necrosis factor-a
Proliferation of T and B-cells; Stimulates IL-1a and §; Acute phase  proteins;
Fever.
5. Interleukin-2 receptors
Mediates: T-cell proliferation; B-cell proliferation; Macrophage activates; TNF, 
IL-1, LAK activity in T- cell.
6. Interleukin-10
Macrophage activator and deactivator; IgA synthesis; Suppresses TNF-a
release; Anti- inflammatory.
7. Interleukin-12
Lymphocyte activation; Increased antibody production; Acute phase proteins; 
Fever.
8. Interferon g
Anti viral; Antiprotozoal; Up-regulate ICAM-1; MHC I and II expression.
__________________________________________________________________
NF-kB TATA
IL-6 gene    CAMP responsive      element (CRE)
c-Fos serum responsive
      element (SRE)
GRE AP-1
ATGCTAAAGGTCACATTGCACAATCT GGGATTTTCC
-173 -145 -73 -64
binding site
IL-1
TNF
MRE NF-IL-6 NF-kB
IL-1
TNF
LPS
IL-1
TNF
Figure 3. Three nuclear factor NF-IL-6, the multiresponse element MRE, and NF-kB are
in the promoter region. These DNA-binding proteins, which are induced by IL-1 and
TNF-a, stimulate transcription of the IL-6 gene. Thus, as IL-1 and TNF-a levels
increase, production of IL-6 also increases.
91.5.1.1. IL-1 system
Interleukin was originally named "Lymphocyte Activating Factor"(LAF) (46) and
was later called other names until "interleukin" was established in 1979 (47).
Interleukin-1 refers to a group of three proteins, i.e. IL-1a, IL-1§, and IL-1ra
(receptor antagonist). Mature IL-1a and IL-1§ are both polypeptides with
molecular weights of about 17.5 kDa. They have different isoelectric points and
two distinct receptors binding both forms of them (48) and have the same
biological functions.
The pro-IL-1§ is processed by an aspartate specific protease called IL-1
converting enzyme (ICE) (49). ICE does not cleave pro-IL-1a.
The type I receptor (IL-1RI) has a cytoplasmic domain of 213 amino acid
residues, and type II (IL-1RII) has only a 29 amino acid residue (50). The IL-1RI
binds IL-1a better than IL-1§ and the IL-1RII binds IL-1§ more strongly than IL-
1a. IL-1RI can signal (51) and the IL-1RII could itself act as an IL-1 antagonist
(52).
IL-1ra competes with and binds to the IL-1 receptor (53). IL-1ra has an affinity
similar to that of IL-1 and its molecular weight is 22 kDa; but IL-1ra does not
transduce any signal (54). IL-1ra occurs also in an intracellular form (icIL-1ra, as
compared to the soluble IL-1ra (sIL-1ra)). icIL-1ra is thought to be important for
blocking IL-1a binding to nuclear DNA (50).
Recently it has been suggested that there is a fourth member of the IL-1 family,
tentatively designated as IL-1g. This is based on amino acid sequence homology
and functional similarities between IL-1a and § and this cytokine has been called
interferon-g-inducing factor (55).
IL-1 can be produced by many different cells, but all nucleated cells are capable
of making this protein under appropriate conditions (42, 56). IL-1 has a wide
variety of effects in immune systems and in the inflammatory reaction to bacteria.
IL-1ra can therefore act specifically to depress the effects of IL-1. Schematic view
of the IL-1 system is shown figure 4. For the recent reviews on IL-1, see (42, 54,
57).
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IL-1 gene
Stimulus
Pro IL-1§
Pro IL-1a
IL-1ra
IL-1§
IL-1ra
IL-1RIIL-1a
ICE
s IL-1RII
"decoy"
No signal
IL-1RII 
"decoy"
Signal
NF-kB
other cytokine
Figure 4. Schematic diagram of IL-1 structure and mechanism of action. Cell stimulation
leads to gene expression of Pro IL-1a and §, followed later by IL-1ra. Pro IL-1§ is then
cleaved at the cell-surface by interleukin-1§ converting enzyme (ICE). The secreted
mature IL-1§ can bind to the type I receptor (IL-1RI) and trigger a cellular level of gene
expression and competition for binding to the IL-1RI (shown by the dotted lines) from
the IL-1ra, surface-bound decoy IL-1RII, and soluble decoy IL-1RII.
1.5.1.2. IL-6 system
It is now well-known that IL-6 is a multifunctional cytokine acting on a wide
variety of cells (41). IL-6 is a 22-29 kDa glycoprotein and was first described due
to its ability to induce the production of immunoglobulin from B cells (58). IL-6
exerts its activity through binding to a high affinity receptor consisting of two
membrane glycoproteins, an 80 kDa receptor protein (IL-6R, or a chain), and a
130 kDa signal transducing protein (gp130, § chain) (59, 60). The presence of IL-
6R together with gp 130 will result in the formation of high-affinity IL-6 binding
and subsequent signal transduction (61, 62). Soluble IL-6R (sIL-6R; 55-60kDa;
15-150 ng/ml) and soluble gp130 (sgp130; 95kDa; 300-400 ng/ml) are present in
the peripheral circulation in humans (63).
There are several cytokines that are closely related to IL-6. They share the
gp130 §-chain as part of their signal transducing receptor complex (table 6). This
subfamily of cytokines also shares some biological activities, such as induction of
acute phase protein response. OM, LIF and IL-6 induce the stasis of certain tumor
types. IL-6 and IL-11 among other things induce megakaryocyte differentiation.
The effects of IL-6 on different cells are numerous and various. The major role
of IL-6 is to mediate inflammation and immune response initiated by infection or
injury. IL-6 have been reported to be associated with a variety of diseases (64),
11
including autoimmune diseases such as arthritis (65), Castleman«s disease,
mesangial proliferative glomerulonephritis, psoriasis, inflammatory bowel disease
and malignancies (66, 67).
Table 6. Interleukin-6-Type Cytokines (68, 69)
____________________________________________
Interleukin-6 (IL-6)
Interleukin-11 (IL-11)
Leukaemia inhibitory factor (LIF)
Oncostatin M (OM)
Ciliary neurotrophic factor (CNTF)
Cardiotrophin-1 (CT-1)
_____________________________________________
1.5.1.3. TNF system
TNF was first identified in the serum of mice challenged with endotoxin after
BCG inoculation (70). TNF-a and § are members of a family of secreted and cell
surface proteins that mediate immune and inflammatory responses. TNF-a, also
called cachectin, is a 17 kDa polypeptide. In a human the TNF-a has 157 amino
acids. TNF is produced by macrophages, neutrophils, activated T and B
lymphocytes, NK cells, LAK cells, astrocytes, endothelial cell, smooth muscle
cells, and some transformed cells (71). TNF-a shows high affinity with two
receptors, TNFRII (Type A, 75kD) and TNF-I (Type B, 55kD) (72). Both
receptors are members of the NGFR/TNFR (nerve growth factor receptor)
surperfamily with four cysteine rich repeats in the extracellular domain (73). The
two types of TNF receptors mediate both overlapping and nonoverlapping
function (table 7). The family of TNF is shown in table 8 (40, 74).
 TNF-a exists in a membrane anchored form on the surface of macrophage and/
or monocytes. The release of soluble TNF-a has cytotoxic activity and plays an
important role in intercellular communication (75). Many of the actions produced
by the TNF-a are functionally similar to those produced by IL-1. A number of
pathological conditions, including Cachexia (76), septic shock following infection
with Gram-negative bacteria (77), autoimmune disorders (78), and meningococcal
septicaemia (79) have increased production TNF-a (80).
12
Table 7. A partial list of signals transmitted through each type of TNF receptor
__________________________________________________________________
TNFR 55 Induction of NF-kB; Induction of c-fos; Stimulation of protein kinase C;
Stimulation of sphingomyelinase; Stimulation of phospholipase;
Production of diacylglycerol; production of ceramide; Induction of IL-6;
Induction of Mn superoxide dismutase mRNA; Prostaglandin E2 
synthesis; Induction IL-2R; HLA class I & II Ag expression;
Antiproliferaton/ cytotoxicity/ apoptosis; Growth stimulation;
Endothelial cells adhesion; Generation of lymphocyte activated killer
(LAK) cells; Proliferation of NK cells; Antiviral activities
TNFR75 Induction of NF-kB; Proliferation of thymocytes; Induction of IL-6
Generation of NK & LAK; DN fragmentation;Antiproliferation/
cytotoxicity/ apoptosis
__________________________________________________________________
Table 8. The TNF superfamily
______________________________________
Receptor Cellular expression
______________________________________
TNFR55 Epithelial cells
TNFR75 Myeloid cells
CD27 Lymphocytes
CD30 Lymphocytes
CD40 B-cells & macrophages
Fas/Apo-1 Myeloid & Lymphoid cells
OX40 CD4+Tcells
4-1BB Activated T cells, thymocytes
NGF-R Neurons, schwann cells &
melanoma cells
_______________________________________
Table 9. Comparison of the Biological Activities of IL-1, IL-6 and TNF-a (43, 81, 82)
______________________________________________________________
Effect IL-1 TNF-a IL-6
______________________________________________________________
Endogenous pyrogen fever + +  +
Synthesis of acute-phase proteins +     +   +
No specific resistance to infection +     + +
Increased vascular permeability +     +   +
Increased adhesion molecules on +     +  -
vascular endothelium
Increased fibroblast proliferation +     +   -
Increased synovial cell collagenase +       +   -
and PGE2
Decreased albumin synthesis +     +   -
Decreased lipoprotein lipase +     +   -
Induction of IL-8 +     +  -
Induction of IL-6 +     +   -
Induction of IL-1 and TNF from +     +   -
monocytes
Platelet production +     -   +
T-cell activation +     +   +
B-Cell activation +     +   +
Increased immunoglobulin synthesis -     -   +
Stem cell activation +     -   +
Endothelial cell activation +     +   -
______________________________________________________________
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1.6. Mechanisms in ODTS
The exact mechanism of ODTS has not been discovered. The ODTS response is
produced by agents which activate different cells, such as macrophages, to excrete
inflammatory mediators (83). This results in leaking of plasma from the
capillaries into the alveolar and pulmonary tissue as well as invasion of cells,
particularly neutrophils through chemotaxis (84-86). There is an increase of
leukocytosis in the BAL, as well as acute phase proteins in peripheral blood (9).
Dust exposure causes TNF-a secretion in the airways, in the lung tissue and the
blood. The TNF-a is subsequently distributed via the blood. High level TNF-a
causes cachexia, tissue destruction and fatigue symptoms. The AM cells produce
an increase in lysosomal enzymes and release different cytokines such as IL-1,
TNF-a, IL-6 and platelet activating factor (PAF) (17, 87-90). The airway
epithelial cells also secrete IL-6. IL-1, IL-6 and TNF-a act on the central nervous
system and induce fever (91-93)(Fig 5).
1.7. The Airway Epithelial Cells
The mature airway is a complex structure lined by a continuous layer of epithelial
cells.  The distribution of cell types within the epithelium varies along the airway.
Table 10 shows epithelial cell types distinguished according to position (basal or
luminal), presence of cilia and secretory granules, the non-epithelial and the
neural component of mature airway epithelial. The surface layer of cells consists
largely of ciliated cells with a few goblet cells (mucus producing) attached to the
basement membrane. These fail to reach the luminal surface and lie sandwiched
between the other varieties of cells. The specialized secretory epithelial of the
submucosal gland is composed of serous cell and mucous cells. In the distal
airway, Clara cells and basal cell are predominant and the epithelial has a more
columnar appearance. At the alveolar levels, the columnar epithelial gives way to
thin epithelial cells. Both are comprised of Type I cells, interspersed with Type II
cells (94, 95). Cellular functions can subdivided into five steps: 1) mucus
secretion; 2) ciliary beating; 3) leukocyte interactions; 4) permeability; and 5)
bronchoconstriction.
The airway epithelial cell barrier induced by environment particles, viruses,
bacteria and cigarette smoke may lead to adverse changes, resulting in airway
inflammation. Specific mechanisms involved in this inflammation include (figure
6): a) increased synthesis and/or release of inflammatory mediators (e.g,
arachidonic acid metabolites, chemotactic agents) or alternatively, decreased
synthesis of protective mediators; b) synthesis of proinflammatory cytokines; c)
modulation of cell adhesion molecules; and d) modulation of immunoregulatory
processes (96-98).
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Figure 5. Mechanisms proposed in the ODTS. It appears that activation of alveolar
macrophages, epithelial cells and lymphocytes with release of pro-inflammatory
cytokines such as IL-1, IL-6, TNF-a, IFN g and chemotactic factors as well as
leukotrienes, oxidants and protease sets the stage for development of ODTS.
Table 10. Mature airway epithelium
__________________________________________________________________
Epithelial cells Ciliated epithelial cells; Basal cells; Dense-core granulated cells;
Mucous secretory cells; Serous secretory cells; Clara secretory
cells; Special-type cells; Brush cells
Migratory cells Lymphocytes; Globule leukocytes; Mast cells
Neural component Neuroepithelial bodies; Never terminals
__________________________________________________________________
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Figure 6. Schematic view of the role of epithelial cells in the modulation of airway
inflammation. For abbreviations, see the section" Abbreviation". ECP: eosinophil cationic
protein; MBP: major basic protein.
1.8. The Alveolar Macrophage
The lung tissue includes four different macrophages: the alveolar macrophage
(AM); the interstitial macrophage; the intravascular macrophage and the dendritic
cell (99). The alveolar macrophages have a unique localization in the body, since
they are placed within the alveolar surfactant film, which is produced by type II
alveolar lining cells and is composed of phospholipids and proteins. In addition,
they are the only macrophages in the body which are exposed to air. They are  the
first line of defence against inhaled constituents of the air. They possess a high
phagocytic and microbicidal potential. The total number of AM in the human lung
is estimated to be 23x109, with approximately 50-100 per alveolus (100).
AM have been reported to produce cytokine (101): IL-1, IL-6, IL-8, TNF, TGF-
§, IFNa § g , GM-CSF, MIP-1a and MIP-1§ (102-104). The production of
individual cytokines is influenced to a great extent by the different stimulus. The
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most widely used stimuli are bacterial  LPS and viruses (105). Adhesion,
endocytosis and secretion are three characteristics of AM. Membrane receptors
and surface markers make AM different function (figure 7). AM has been shown
to produce metabolites of arachidonic acid, both along the cyclo-oxygenase
pathway (the thromboxances and prostaglandins) and the lipoxygenase pathway
(the leukotrienes and hydroxyeicosatetraenoic acids HETEs)(106). AM produces
the reactive oxygen intermediates (ROIs), such as superoxide anion (O2,
hydrogen peroxide (H2O2) and hydroxyl radical (OH-), in association with
phagocytosis (107). AM also efficiently kills microbial and can clear certain
bacteria, viruses and fungi (108).
. 
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Figure 7. Macrophage receptor and its ligands
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2. Aim of the Present Study
The purpose of this thesis is to characterize the appearance of acute phase
cytokines in ODTS and to correlate the acute health effects with markers for
microbial contaminants in inhaled swine dust causing ODTS. The specific aims of
the present study are:
1. To study the time course of changes in TNF-a and IL-6 in peripheral blood
after acute exposure to swine dust (study I).
2. To evaluate the release of pro-inflammatory cytokines IL-1, IL-6 and TNF-a in
the upper and lower airways following exposure to airborne swine dust (study II).
3. To investigate the correlation between markers for microbial contaminants in
the dust, cytokine responses, and health effects (study III).
4. To study if the IL-1 family of cytokines increase in peripheral blood after
inhalation of swine dust (study IV).
5. To study release of proinflammatory cytokine producing cells, from an
epithelial cell line (A549) and human alveolar macrophages in vitro  stimulated
through exposure to swine dust or LPS (study V).
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3. Materials and Methods
In this section a summary of the design of the experiment and the methods used is
given. More details are given in the original papers.
All subjects gave written consent after being informed about the experiment,
and the human studies were approved by the local Ethics Committee of
Karolinska Institute  (KI No 92:74, 93:3, 93:45, 93:223 and 95:347).
3.1. Swine Dust Exposure: Studies in Humans
3.1.1. Subjects
All participants were healthy non-smoking volunteers. They had no previous
exposure to farm dusts. All denied present or past symptoms of allergy or asthma.
None had experienced respiratory infections in the two weeks preceding the study.
All subjects in study I were included in study III, but none were included in study
II. All subjects in study II were included in study III and some of them were
included in study IV. Details about subjects for the four experiments are given in
table 11.
Table 11. Subjects in four human exposure studies
                          I                       II                      III                      IV                  _
Number 14 22 38 36
Sex: F/M 8/6 9/13 22/16 16/20
Age 29 30 30 31
(range)             (19-45)             (22-50)             (18-50)             (18-59)             _
overlapping                                                        I+II                  II (16)+others__
3.1.2. Study Design
Each subject spent 3-4 hours inside a swine confinement building containing
about 700 swine, with a body weight of about 100 kg. During this time the swine
were guided through a weighing box, a procedure that causes considerable
aerosolisation of settled dust. On testing occasions one or two subjects were
present. On those testing occasions when two subjects were present, they worked
in close proximity to each other. The study design process is shown in figure 9.
All participants responded to a symptom questionnaire containing questions about
shivering, headache, weakness, muscle pain, and nausea. Table 12 describes the
tests used in the studies.
In paper I, we studies the time course and peak levels of cytokine concentration
in peripheral blood after exposure to swine dust. Six subjects participated the
study. The blood samples were taken at 2, 5, 7, 9, 11 and 24 h after the start of the
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exposure for IL-6 analysis in serum. When the TNF high sensitivity kits were
available, another eight subjects were involved and additional blood samples were
taken at 3 h.
In paper II, cytokine (IL-1a, IL-1§, IL-6 and TNF-a) concentrations in the
BAL and NAL samples were measured. Albumin was also analyzed in BAL and
NAL fluid. As a control experiment, BAL fluid from seven subjects, was
concentrated 14-fold by lyophilization and was subsequently analysed in order to
compare the results from QuantikineÔ kits and high sensitivity Quantikine kits.
The sensitivity of IL-1a assay was improved by adding the ELASTÒ
amplification system.
In paper III, the quantity of inhaled dust and different markers of exposure to
microorganisms were correlated to health effects including changes in lung
function (BHR, FEV1, and VC), serum IL-6, peripheral blood leukocytes and
neutrophils, body temperature, and other symptoms.
In paper IV, different methods to analyse IL-1§ were compared. In one method
isolated PBMC were studied. IL-1§ was measured in PBMC (n=16) and poor
platelet plasma (n=8). Blood samples from eight subjects were taken at 3, 4, 7,
and 24 h in order to study time course the release of IL-1§. The percentage of
mononuclear cells was measured in PBMC. Levels of IL-6, TNF-a and IL-1ra
were analysed in the serum.
 
Exposure in 
swine house 
7 H0 H 24 H3 H
-Spirometer 
-Methacholine
-NAL *
-BAL 
-Blood *
-Temperature *
 
-Personal dust sample
-Endotoxin
-Inhalable dust
-Respirable dust
-Muramic acid
-3-OH fatty acid
-NAL
-Blood
-Spirometer
-Methacholine
-Temperature
-BAL
-Blood
-Temperature
3-14 day
 before
Figure 9. Measurement performed on the exposure day
* Performed 30 minute before exposure
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Table 12.  Tests performed in different studies
test I II III IV
_________________________________________________________________
Lung function Ö Ö Ö Ö
Methacholine test Ö Ö Ö Ö
BAL cytokine Ö
NAL cytokine Ö
BAL cells Ö
NAL cells Ö
Temperature Ö Ö Ö Ö
leukocytes in blood Ö Ö Ö Ö
Albumin in BAL Ö
Albumin in NAL Ö
CRP Ö
IL-1 Ö Ö
IL-6 Ö Ö Ö Ö
TNF Ö Ö Ö
IL-1ra Ö
________________________________________________________
3.1.3. Lung Function and Bronchial Challenge Tests
FEV1 and VC were measured with a low-resistance rolling-seal spirometer
(OHIO model 840, Airco, Madison, WI). The protocol followed the guidelines of
the American Thoraxic Society (109). Local reference values were used (110,
111).
 Bronchial responsiveness was measured with a methacholine bronchial
provocation test. Inhalation of diluent was followed by doubling (study I, II, III)
or four-doubling (study III, IV) concentrations of methacholine starting at 0.5
mg/ml until FEV1 had decreased 20 % compared with the volume obtained after
inhalation of the diluent or until the maximum concentration was reached. The
PD20FEV1 was calculated. The method is standardized with control of inhalation
flow (0.4 l/s), inhalation volume (0.8 l), and number of breaths. The output of the
nebulizer (0.38±0.01 ml/min) was measured daily. The details of the procedure
have been described elsewhere (112).
3.1.4. Exposure Measure
In the present study, two different dust fractions were measured. Dust is classified
by size into two primary categories: (113)
* Respirable dust, size <5 mm, reaching the alveolar  region.
* Inhalable dust, size £10 mm, most of which is trapped in the nose, throat and
upper airway.
3.1.4.1. Inhalable dust, respirable dust and endotoxin
Inhalable dust and endotoxin were sampled at an airflow of 1.9  to 2.0 L/min
during the exposure with personal samplers using 25 mm IOM head open-phase
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filter cassettes and portable pumps (SKC Ltd, Dorset, UK). The airflow was
calibrated before and after exposure. The cassettes were carried in the breathing
zone and were equipped with 0.4 mm polycarbonate filters (NucleporeÒ; Costar
Corp., Cambridge, MA). The subjects also carried CycloneÒ samplers (study I,
IV) for measurement of the respirable dust fraction (Cyclone, cut-off 5mm; SKC).
Inhalable dust and the respirable dust were measured by weighing after 24 h of
conditioning, using a ME 22 MettlerÒ balance (Mettler, Greisensee, Switzerland)
and reference filters.
Endotoxin was measured after suitable dilution with a chromogenic version of
the Limulus amebocyte lysate assay (QCL-1000, Endotoxin with Escherichia coli
0111:B4 as standard; BioWhittaker, Walkersville, MD).
3.1.4.2. Microbial Markers
Samples were analyzed by gas chromatography-mass spectrometry (GC-MS) for
peptidoglycan and lipopolysaccharide by using muramic acid (MuAc) and 3-
hydroxylated fatty acids (3-OH FAs) respectively, as chemical markers. The filter
extracts were transferred to test tubes equipped with Teflon-lined screw caps,
dried, and heated overnight at 100 °C in 4M hydrochloric acid. Thereafter, 1 ml of
hexane was added to each tube and after shaking, the hexane phase was
transferred to a separate tube. The hexane phase was evaporated to dryness,
heated overnight in 4M methanolic HCL at 100 °C, extracted, purified by using a
disposable silica gel column, subjected to trimethylsilyl (TMS) derivatization, and
analyzed for 3-OH fatty acids as described in detail previously (114). The aqueous
(acidic) phase was evaporated, subjected to TMS derivatization, and analysed for
MuAc (115). Table 13 gives exposure measure in the four studies.
Table 13.  Measurement of dust and microbial marker
Test I II III IV
_______________________________________________________________
Inhalable dust Ö Ö Ö Ö
Respirable dust Ö (n=7) Ö (n=8)
Endotoxin Ö Ö Ö Ö
muramic acid Ö Ö
3-OH fatty acid Ö Ö
_______________________________________________________________
3.1.5. Blood sampling
Samples for cytokine analyses were obtained in vacuatainer silicone tubes and
samples for flow cytometry were obtained in EDTA tubes manufactured by
Terumo Venoject ( Terumo Europe, Belgium). Samples were allowed to
coagulate for 1-1.5 h at room temperature and centrifuged using a Sigma 3K-2
refrigerated centrifuge (Axel Johnson, Helsingborg, Sweden). Supernatants were
transferred to small glass tubes and stored in freezer at -70°C pending analysis.
Each sample underwent only one freeze-thaw cycle before assay.
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In paper IV, PBMC were obtained using Ficoll-Paque and Histopaque method
and sterile tubes were used in the whole process. Poor platelet plasma sample and
chloroform extraction in plasma were prepared.
Chloroform extraction was found to provide the best recovery of exogenous IL-
1§. 1 ml plasma and 2.0 ml of chloroform were agitated for 5 minutes, and spun
for 5 min at 10,000 g, 4 °C (Beck Man Model J2-21). The aqueous phase was
separated and recovered. The extraction procedure was repeated two times.
The blood tubes were centrifuged immediately after venipuncture (400 ¥ g for
10 minutes). Plasma was removed without disturbing the buffy coat, aliquoted in
1.5 ml microfuge tubes and was spun at 1600 ¥g at 3000 RPM for 10 minutes to
pellet the platelets. The platelet free plasma was transferred to new microfuge
tubes and frozen until assay.
3.1.6. Flow Cytometry
This method was employed to examine total blood and the proportion of
polymorphonuclear granulocytes, monocytes, and lymphocytes (Epics Profile
IIÒ; Coulter Corp., Hialeah, FL). The samples were prepared in a COULTER Q-
PREP (Coulter Electronics Inc, Hialeah, FL, USA) and incubated for 10 minutes
with CD14-CD45 monoclonal antibodies (Mo2-RD1/ Kc56-Fitc, Cytostat
Ò/Coulter CloneÒ, Coulter Corp, Hialeah, Florida).
3.1.7. Cytokine assays
The cytokines analyses were performed using the commercial enzyme
immunoassays (R&D Systems Europe, Abingdon, UK) and according to the
manufacturer's instructions. This test is based on a "Sandwich" assay, in which  a
monoclonal antibody specific for IL-1§, IL-1ra, IL-6 and TNF-a has been pre-
coated onto the microtier plate. Any cytokine present is bound by the immobilized
antibody. After washing away any unbound proteins, an enzyme-linked
polyclonal antibody specific is added the wells to "Sandwich" any IL-1§, IL-1ra,
IL-6 and TNF-a immobilized during the first incubation. Following a wash to
remove any unbound antibody-enzyme reagent, a substrate solution is added to
the wells and color develops in proportion to the amount of cytokine bound in the
initial step. The color development is stopped and the intensity of the color is
measured. A curve is prepared, plotting the Optical Density (OD) versus the
concentration of those cytokine in the standard wells. By comparing the OD of the
samples to this standard curve, the concentration of the IL-1§, IL-1ra, IL-6 and
TNF-a in the unknown sample is then determined. The cytokines detection limits
and CV showed in table 14.
To this method an amplification system was added to construct a high-
sensitivity system. In this amplification system a reaction with alkaline
phosphatase provides a co-factor activating a redox cycle leading to formation of
a coloured product. IL-1a was analyzed using commercially available kits (R&D
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Systems Europe, Abingdon, UK) with ELASTÒ amplification system (DuPont,
NenÒ, Boston, MA, USA). The principles of the two amplification systems are
given in figure 10. The standard curve for IL-1a was between 0.49 and 31.3 ng/L.
Table 15 gives reference values in healthy subjects from our laboratory samples.
Table 14. Detection limits and coefficients of variation (CV) intra- and inter assays for
IL-1, IL-6 and TNF using normal QuantikineÔ and high sensitivity EASIAÔ kits
Cytokine Detection CV CV Detection CV     CV
limit ng/L inter% intra% limit ng/L inter%   intra%
_________________________________________________________________
QuantikineÔ EASIAÔ
________________________ ________________________
IL-1a 3.9 < 8 < 8 0.49 < 10    < 7*
IL-1§ 3.9 < 6 < 3 0.125 < 9    < 9
IL-6 1.5 < 4 < 3 0.156 < 11    < 6
TNF-a 15.6 < 6 < 5 0.5 < 9    < 6
IL-1ra 46.9 < 5 < 5
__________________________________________________________________
* IL-1a  EASIA improvement by our laboratory.
2. Redoxsystem AL P
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Figure 10. Amplified substrate system
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Table 15. Reference values from our laboratory  (IL-1, IL-6 and TNF) from healthy
individuals using QuantokineÔ(Q) and EASIA Ô (HS) kits
Detectable Detectable
Cytokine Sample type N Mean ng/L Range ng/L
__________________________________________________________________
IL-1a (Q) Serum 20 < 3.9
IL-1§ (Q) Serum 24 < 3.9
IL-1§ (HS) NAL 33 2.82 0.167-6.62
IL-1ra (Q) Serum 40 250 95 - 880
IL-6 (Q) serum 71 < 3.13
IL-6 (HS) serum 43 1.02 0.156-4.89
NAL 124 1.9 0.11-14.53
BAL 59 0.71 0.156-2.3
TNF-a (Q) Serum 20 < 15.6
TNF-a (HS) Serum 56 1.93 0.25-8.93
NAL 67 0.281 0.27-2.16
BAL 65 0.298 0.25-1.37
__________________________________________________________________
3.1.8. Methodology
When measuring cytokines in biological fluids, some pitfall can be encountered.
The factors that affect cytokine measurement also influence cytokine activity in
vivo, thus they are important for methodological standpoint (116, 117)
It is important that the samples for cytokine analysis are taken in endotoxin free
tubes (118). The blood evacuated collection tube was measured from random
sample for endotoxin with the LAL assay in our laboratory.
In order to minimise the variability of the assay  only R&D system kits were
used in our test (119).
The minimum detectable concentration of IL-6 was determined by adding two
standard deviations to the mean OD value of 20 zero standard replicates and
calculating the corresponding concentration from the standard curve.
For both kits (EASIAÔ and QuantikineÔ), the CV is less than 10 % in intra-
and interassays with the acceptable value. IL-6 concentrations were determined in
the same samples (n=30) using both EASIAÔ and QuantikineÔ kit.
3.1.9. Nasal Lavage
Using a syringe, five ml of room temperature isotonic saline solution  (0.9 %) was
instilled into each nasal cavity while the subject gently flexed the head backward
(approximately 30û from the horizontal plane) while closing the soft palate. This
position was maintained for 10 seconds, after which the subject leaned forward
and expelled the nasal fluid into a plastic collection cup. The lavage fluid was
immediately centrifuged at 200 g, +4ûC, for 10 minutes, and the supernatant was
frozen in aliquots at -70 ûC until analyzed.
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3.1.10. Bronchoalveolar Lavage (BAL)
Bronchoscopy was performed through the mouth with a flexible fibreoptic
bronchoscopy (Olympus Type 4B2) under local anaesthesia with 2% lidocaine
(Xylocaine, Astra, Sdertlje, Sweden) after premedication with benzodiazepine
and atropine. The bronchoscope was wedged in a middle lobe bronchus and sterile
saline solution at 37 ûC was instilled in five aliquots of 50 ml. After each
instillation, the fluid was gently aspirated and collected in a siliconized plastic
bottle kept on ice. The cellular component was immediately centrifuged at 400 g
for 5 minutes at 4 ûC, and the supernatant was frozen in aliquots at -70 ûC for
subsequent analysis. The BAL technique has been described in detail elsewhere
(120).
3.1.11. Nasal and BAL Cell Determination
Nasal and BAL cells were counted in a Brkerchamber. A cell smear was stained
with the May-Grnward-Giemsa stain, in order to make a differential cell count.
3.1.12. Protein Analysis
Albumin was analyzed using a sandwich ELISA developed by our laboratory.
Each plate was calibrated with human serum protein (Dakopatts, Glostrup,
Danmark). Orosomucoid was analyzed by immunoeletrophoresis using
commercial antiserum (Dakopatts, Glostrup, Denmark). C-reactive protein (CRP)
was analyzed using nephelometry with the NA Latex CRP reagent (Behring,
Frankfurt am Main, Germany).
3.2. Swine Dust Exposure: Studies in vitro
3.2.1. Epithelial Cells
The human lung epithelial carcinoma cell line A549 (American Type Culture
Collection, Rockville, Maryland, USA. CCL 185) was used in the study. The cells
were cultured in Ham's F-12 supplemented with penicillin/streptomycin (1%), and
heat-inactivated (56 ûC 1H in oven) fetal calf serum (FCS). Frozen cells were
taken from liquid nitrogen and were seeded onto 80 cm2 plastic flasks and grown
to confluence in humidified atmosphere with 5 % CO2 at 37 ûC for 5 to 7 days.
The cells were removed from the flask through trypsin/EDTA treatment and
seeded onto 6-well plates to a final concentration of 9 *105 cells per well. The
cells were at subconfluency stimulated with LPS or swine dust of concentrations
of 12.5, 25, 50 and 100 mg/ml in triplicate or quadruplicate and incubated for 8
hours in medium without serum. Control media were  prepared from cell-free
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dishes in the same manner. The supernatants were collected, centrifuged (1000 g,
10 min at 20 ûC) and analysed using the ELISA method.
3.2.2. Alveolar Macrophages
The alveolar macrophages (AM) were obtained by BAL from six healthy
volunteers. The lavage fluid was immediately centrifuged at 200 g for 10 minutes
at 4 ûC. The cells were then resuspended in RPMI medium supplemented with 5%
FCS (heat-inactivated), 1% penicillin/streptomycin + 50 mg/ml gentamycin. A
volume of 2 ml containing 106 cells was dispensed in each well of 6-well culture
plates and incubated for 2 h at 37 ûC in 5 % CO2. Non-adherent cells were
removed after 2 h through washing with RPMI and the adherent cells were
incubated for 18 h. After about 18 hours of incubation, the cells were washed with
RPMI medium and stimulated with LPS or swine dust at concentrations of 12.5,
25, 50 and 100 mg/ml, incubated for 8 h in serum-free RPMI medium. The
supernatants were collected and centrifuged (1000 g, 10 min at 20 ûC) and stored
at -70 ûC until  assay. Control media were prepared from cell-free dishes in the
same manner. 
3.3. Statistics
Results are presented as mean± SD (paper I), mean± SEM (paper II, V) and
medians of 25th - 75th percentiles (paper I, II, III). Comparisons were performed
by the use of the Wilcoxon signed rank test (paper, I, II, III, IV). The differences
were considered significant when p<0.05. The JMP statistics program was used
for calculation of Pearson correlation coefficients and Spearman r (rho, non-
parametric correlation, pairwise comparisons, as shown in paper II, III, IV). The
Statview II software statistics program (Abacus Concepts, Inc.) was used for
stepwise multiple regression and linear regression (paper III). In paper V, analysis
of variance (ANOVA, Abacus Concepts, Inc) and a Fisher's PLSD test was used.
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4. Results
4.1. Human exposure studies
4.1.1. Lung Function and Challenge Test of Subjects
As shown in table 16, the result of the lung function test before and after exposure
is slightly different among the subjects. However, the changes are statistically
significant. FEV1 were 5-6% lower at 7 h after the start of the exposure. The lung
function results are similar and P value was less than 0.01 since the subjects were
overlapped in each study. VC changes were 2-3% lower in the four studies and p<
0.05. After exposure, PD20 for methacholine dose fell about 4-10 fold (p< 0.001)
in the test .
4.1.2. Dust Levels
The dust levels were high in our studies. The average airborne inhalable dust
concentration was 20-23 mg/m3. The respirable dust levels were 0.7-1.0 mg/m3.
In paper I, seven subjects were analysed and in paper IV eight subjects were
analysed. For the microbial marker, the result in paper III was slightly higher than
that in paper II. (table 17).
Table 16. Details of the Subjects Lung function and challenge mean(SD) or median (Q25-Q75)
__________________________________________________________________
FEV1 VC         PD20 FEV1 VC
    in % pred value         mg/ml L L
__________________________________________________________________
I** Before 101 (10) 101 (9)        2.5 (1.2-5.4) 4.2 (0.6) 5.2 (1.1)
  After         0.2 (0.1-0.7)* 3.9 (0.5)* 5.0 (1.1)*
II Before 101 (11) 101 (10)      5.2 (1.3-24) 4.4 (0.9) 5.4 (1.0)
  After         0.7 (0.2-1.2)* 4.2 (0.9)* 5.3 (1.0)*
III Before 102 (7) 101 (9)        4.4 (1.3-22) 4.2 (0.8) 5.3 (1.0)
  After         0.5 (0.2-1.0)* 4.0 (0.8)* 5.1 (1.0)*
IV Before 99 (11) 97 (10)        2.7 (1.1-11) 4.1 (0.9) 5.1 (1.2)
After         0.3 (0.1-0.7)* 3.9 (0.9)* 5.1 (1.0)*
__________________________________________________________________
* mean P< 0.05
** Eight subjects performed challenge test 24 hours after exposure and six subjects
performed challenge 7 hours after exposure.
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4.1.3. Systemic Health Effects
The participants responded to a symptom questionnaire and the symptoms were
classified on a five-graded scale (1-5) where 1 denoted no symptom and 5 very
strong symptoms. The following table shows symptoms after exposure to swine
dust for each study. The subjects with symptoms graded 4 and 5 are counted and
listed in table 18.
Oral temperature rose slightly after exposure and reached the highest levels at
7h. Comparing the non-exposure value for each person with the value after
exposure, the temperature changes are between 0.6-0.9 ûC. The results are given
in table 19.
Table 17. Exposure levels median (25th -75th percentiles)
__________________________________________________________________
paper I paper II paper III paper IV
Inhalable dust (mg/m3)      22.5 (20-24)       20.5 (14.6-30) 21 (16-25) 23 (20-30)
Respirable dust (mg/m3)     0.7 (0.4-1.4) 1.0(0.1-1.2)
Endotoxin (mg/m3)       1.2 (0.9-1.4)         1.2 (0.8-1.4) 1.2 (0.9-1.4) 1.1(0.8-1.4)
Muramic acid (mg/m3)          0.9 (0.3-1.9) 1.0 (0.4-1.9)
Peptidoglycan (mg/m3)          6.0 (2.0-12.7) 6.5 (2.7-13)
3-OH fatty acid (mg/m3)          3.5 (2.2-4.5) 3.9 (2.5-4.9)
___________________________________________________________________
Table 18. Symptoms in each study (according to the subject«s grading)
_________________________________________________________________
Symptom      I II III IV
     N=14      N=21      N=35 N=36
_________________________________________________________________
Fever      1 (37.9°C)    3 (>38°C)     4 (>38°C) 5 (>38°C)
Shivering      2 2 4 5
Headache      2 2 3
Malaise      5 4 9 10
Muscle pain      1 1 2 3
__________________________________________________________________
Table 19. Temperatures at different time points  (Mean±SEM)
___________________________________________________________________
Time I (ûC) II (ûC) III (ûC) IV (ûC)
___________________________________________________________________
Before exposure 36.4 (0.12) 36.2 (0.09) 36.3 (0.07) 36.2 (0.09)
After 5 hour 36.3 (0.12) 36.5 (0.09) 36.4 (0.07) 36.5 (0.07)
After 7 hour 37.0 (0.10) 36.7 (0.07) 36.8 (0.06) 36.8 (0.08)
After 24 hour 36.7 (0.2) 36.2 (0.08) 36.3 (0.07)
D temperature   0.6 (0.2)   0.9 (0.14)   0.8 (0.11)   0.9 (0.14)
___________________________________________________________________
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4.1.4. Relationship between Temperature And Cytokines Changes
In paper III, nine subjects demonstrated temperature increases that were greater
than 1.5 °C. These occurred seven to nine hours after exposure. Four of them had
fever (T over 38°C). Two of the four fever subjects had the highest IL-6 levels in
all of the exposure population. These two individuals had chill symptoms graded
4 and the temperatures were 38.2 °C and 38.1°C, respectively. IL-6 in serum was
increased to 124 ng/L and 128 ng/L. The other two subjects experienced great
fatigue and adynamia.
4.1.5. Time Course of Cytokine Release after Inhalation of Swine Dust (paper
I and IV)
TNF-a  in serum increased from 2.5 (1.8 - 3.1) ng/L (median, 25th-75th
percentile) before exposure to maximum values of 10.0 (4.6 - 15.7) ng/L between
3 and 5 h after the start of exposure. IL-6 increased from less than 1.5 to 21.4
(18.6 - 33.6) ng/L 4 to 11 h after the start of exposure. Maximum IL-6 occurred 1
to 5 h after the maximum TNF-a However, in some cases an early increase in IL-
6 parallel to the change in TNF-a was observed (the details are shown in paper I,
figure 1). There was a significant correlation between maximum TNF-a and IL-6
values (r2=0.48, P<0.01). TNF-a levels returned to baseline 7 hours after
exposure. The levels of IL-6 were still significantly increased at 12 hours
(P<0.01), but not 24 hours after the start of exposure (figure11- 1, 2).
Peak levels of TNF-a and IL-6 were reached at 4 (3-5) and 7 (4-9) hours after
the start of the three hours period of exposure respectively. Although the TNF
peak always preceded maximal IL-6 values, smaller increases in IL-6 parallel to
the TNF change were observed. There was a considerable variability in the
temporal relations between TNF and IL-6. Thus peak levels of TNF-a preceded
the maximum IL-6 level by only a 1 1/2 hour difference in some cases and up to
five hours difference in other cases.
IL-1§ in PBMC increased from 1.6 (1.3-2.5) ng/L (median, 25th-75th
percentile) before exposure to 4.3 (2.7-5.2) ng/L at 7 h after the start of exposure.
Maximum IL-1§ occurred at 4 to 7 h after the exposure. The level increased
significantly at 3, 4 and 7 h, but not at 24 h (figure 11-3).
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Figure 11. TNF-a (n=8), IL-6 (n=6) in serum and IL-1§ (n=8) in PBMC fraction in
previously non-exposed subjects at different times before and after the start of the three
hours exposure to swine dust.
4.1.6. Cytokine Release in Upper and Lower Airways (paper II)
IL-6 increased approximately 25-fold (from 0.43 (0.21-0.78) ng/L to 11.6 (8.1-
21.0) ng/L, P<0.001) in BAL fluid and 15-fold (from 1.4 (0.6-2.6) ng/l to 21 (14-
40) ng/L, P<0.001) in NAL fluid after exposure to swine dust. TNF-a in BAL and
NAL fluid was below detection limits (0.25 ng/L) in most subjects before
exposure and increased to 3.8 (2.4-5.7) ng/L and 1.3 (0.6-2.3) ng/L respectively,
after exposure (P< 0.001). In BAL fluid there was a slight but significant increase
in IL-1a and IL-1§ (P< 0.005), while the increases in NAL fluid were more
pronounced; medians of 3.2 (2.2-5.8) to 6.0 (5.6-9.3) ng/l (P< 0.01) and 2.6 (0.8-
3.9) to 8.5 (6.2-19.8) ng/L (P<0.001) respectively. See figure 12.
4.1.7. Cytokine Relationship in Different Body Fluids
In paper II IL-6 values in BAL fluid collected 24 hours after exposure were
compared with serum values obtained at the same time point. IL-6 in NAL
collected at 7 h after the start of the exposure were compared with serum collected
7h after exposure in spite of a marker dilution of the biological fluid collected in
NAL and BAL fluids. The IL-6 values were higher than in serum (figure 13).
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Figure 12. Cytokine concentration in BAL and NAL. BAL sample was taken at 24 h and
NAL sample was taken at 7 h after the start of exposure. Median and 25th-75th
percentiles are presented.
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Figure 13. IL-6 derived from NAL and blood (paired data)  at seven hours after
exposure. IL-6 derived from BAL and blood (paired data) at twenty-four hours after
exposure. * denote subject have the fever (4 cases)
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4.1.8. Correlations
4.1.8.1. With microbial markers
All markers for exposure showed significant positive correlations with increases
of IL-6 in serum according to the non-parametric Spearman test. The three
markers for microbial exposure showed statistically significant correlations with
at least one additional health effect, but the amount of inhalable dust did not
correlate significantly with any other health effect according to the Spearman test
(III table 2).
Endotoxin generally gave higher correlation coefficients than those of 3-OH
Fatty acid, and demonstrated the highest linear correlation with IL-6. Endotoxin
also correlated significantly with symptoms and the lung function measures VC
and PD20 FEV1. Muramic acid correlated with the temperature change at 7 hours
and with changes in peripheral blood granulocytes (and IL-6 as described above),
but did not correlate significantly with symptoms and lung function changes.
There were moderate correlations between different markers for health effects
within subjects (III table 2).
4.1.8.2. With health effect
Significant correlations were found for all combinations of change in VC,
PD20FEV1, IL-6 and neutrophils, except for the change in VC and neutrophils,
which did not quite reach significant levels (paper III, table 3). The 7 h
temperature correlated with maximal IL-6 levels after exposure, p<0.001 (figure
14).
The peptidoglycan concentration in the filter sample also correlated with the
temperature change at 7 h (paper III, figure 3).
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Figure 14. Relationship between maximum IL-6 value and 7 hour oral temperature (°C)
R^2 = .287 p< 0.01
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 4.1.8.3. In BAL fluids
There was a significant correlation between post-exposure IL-6 levels in BAL
fluid and the endotoxin activity (Rho=0.49; P< 0.05) and 3-OH fatty acid
concentrations (Rho=0.47; p< 0.05) of inhaled dust. No other significant
correlations were found between exposure and the cytokine response in lower or
upper airways. A weak but significant correlation was found between the increase
in albumin in BAL fluid and the endotoxin activity in inhaled dust (Rho=0.48, p<
0.05). Post-exposure levels of IL-6 and TNF-a in BAL fluid were significantly
correlated with the increase of granulocytes (Rho=0.55; p< 0.02 for both).
4.1.8.4. With IL-1 family
The endotoxin concentration correlated with IL-1§ in PBMC and the respirable
dust concentration correlated with IL-1§ in plasma. IL-1§ also correlated with
PD20FEV1, temperature change and leukocyte count (Paper IV, table 4 and figure
15).
The concentration of inhalable dust  correlated with IL-1ra at 7 h. The TNF-a
and IL-6 also correlated with IL-1ra (figure 16). IL-1ra was correlated with
challenge test, temperature and white blood cell count. The details are given  in
paper IV, table 4.
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4.1.9. Acute Phase Proteins and Albumin
In the paper I, serum CRP, orosomucoid and haptoglobin levels were significantly
elevated 12 to 24 hours after exposure. This is shown in table 20.
The albumin concentration in BAL and NAL fluid approximately doubled,
respectively. See table 21.
4.1.10. Leukocytes Response in Peripheral Blood Cells, BAL and NAL.
The peripheral blood leukocyte count reached maximum levels 7 hours after the
start of exposure, mainly due to a rise in the concentration of granulocytes (table
22).
The granulocyte concentration in BAL fluid increased more than 50-fold. The
number of lymphocytes and monocytes was more than doubled following
exposure, p<0.01 and 0.001, respectively. The total cells in NAL fluid increased
after exposure. Prior  to exposure, differential count NAL was possible only on 13
subjects. The number cells increased,  see table 23.
4.1.11. Mononuclear Response in PBMC Fraction
In the mononuclear cell fraction (n=8), the lymphocytes decreased and the
monocytes increased. The lymphocytes decreased from 2.3 ±0.2 (mean±SE) at 0
h, to 1.6(±0.2)*109 cell /L at 7 h after the start exposure (p< 0.01). The
monocytes increased from 0.5±0.1 at 0 h, to 0.7(±0.1)*109 cell /L at 7 h after the
start exposure (p< 0.01). The mononuclear percent, see also paper IV, figure 1.
Table 20. Measurement of CRP, orosomucoid, and haptoglobin in serum. Analyses
before exposure time, 12 and 24 hours after exposure .
Time C R P mg/L Orosomucoid g/L Haptoglobin g/L
n = 14 n = 14 n = 14
before 0.90±1.10 0.74±0.13 1.15±0.23
12 hour 1.87±1.57 * 0.79±0.16 ** 1.16±0.24
24 hour 10.0±8.42 ** 0.87±0.15 ** 1.38±0.21 **
 *  P< 0.05 compared with pre-exposure values.
** P< 0.01 compared with pre-exposure values.
Table 21. Albumin levels in BAL and NAL (paper II)
Before After
mg.L -1 mg.L -1
BAL n= 22 20.73 40.6 *
    (±8.6)    (±17.2)
NAL n= 16 24.5 51.7 *
   (±24.2)    (±72.5)
BAL sample is collected 24 hours after exposure. and  NAL sample is collected 7 hours
after exposure. * p< 0.001 compared with non-exposure value.
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Table 22. The change of peripheral blood leukocyte count
______________________________________________________________________
Granulocyte Lymphocyte Monocyte
0 h 7 h 24 h 0 h 7 h 24 h 0 h 7 h 24 h
(L/10*9) (L/10*9) (L/10*9)
_______________________________________________________________________
Paper I n=12 Mean 2.6 7.1 4.6 1.8 1.3 1.6 0.3 0.5 0.4
   SD (0.8) (1.5) (1.9) (0.3) (0.3) (0.3) 0.1) (0.1) (0.1)
Paper II n=22 2.4 6.3 3.8 1.8 1.3 1.4 0.3 0.5 0.4
(0.6) (2.4) (1.5) (0.4) (0.4) (0.3) (0.1) (0.2) (0.1)
Paper III n=38 2.4 6.6 4.1 1.8 1.3 1.5 0.3 0.5 0.4
(0.7) (2.0) (1.6) (0.3) (0.4) (0.3) (0.1) (0.2) (0.1)
Paper IV n=32 2.3 6.6 3.9 1.7 1.4 1.5 0.4 0.5 0.4
(0.7) (2.0) (1.4) (0.5) (0.5) (0.5) (0.1) (0.2) (0.1)
____________________________________________________________________
Table 23. Leukocyte count in BAL and NAL fluid before and after exposure (paper
II)
_____________________________________________________________________
BAL NAL
Cell count 10*6/L Cell count 10*6/L
before after before a fter
____________________________________________________________________
Granulocyte Median 1.9 107 2.7 121*
25-75 (1.0-2.4) (53-199) (0.3-13.1) (45-229)
Lymphocyte 4.9 10.0
(3.1-8.7) (6.3-19.9)
Monocyte 85 188
(68-99) (133-275)
Total cell 91.8 306 3.6 79**
(47-95) (157-315) (1.8-7.4) (35-185)
____________________________________________________________________
* N=13, **N=22
4.2. In vitro experiment
Swine dust, but not LPS, induced a marked dose-dependent release of IL-6 from
epithelial cells. There was no IL-6 activity in cell free control samples. TNF-a
and IL-1§ were not detected in epithelial cell supernatants, following either swine
dust or LPS exposure. After 8 or 24-hour incubation with rTNF-a  or rIL-1§,
TNF-a  recovery was 80-84 % and the IL-1§ recovery was 74-84 %.
Compared to the unstimulated control situation, swine dust induced a 500-fold
increase, TNF-a  induced a 200-fold increase and a combination of swine dust
and TNF-a  caused a 1700-fold of IL-6 (paper V, Fig 2). However, IL-1§ did not
induce IL-6 production in epithelial cells and neither did a combination of IL-1§
and swine dust .
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Swine dust and LPS caused a dose-related increase of IL-6, IL-1§ and TNF-a
in AM (Fig 17). Control media without cells but identically incubated with swine
dust or LPS did not show any cytokine activity. TNF-a  was significantly
increased at all the dose levels following swine dust and LPS exposure, LPS being
significantly more potent than swine dust . At the two high dose concentrations,
LPS was significantly more potent than swine dust at inducing IL-6 secretion
from AM. Swine dust and LPS were equally potent induces of IL-1§ in alveolar
macrophages.
4.3. Methodology
There was no endotoxin has been detected in evacuated blood collection tubes.
For our IL-6 assay the minimum detectable concentration using diluent RDF6 was
found to be 1.5 ng/L (figure 18).
The relationship between the EASIAÔ and QuantikineÔ kits are given in
figure 19. These two kits are made up of exactly the same protein in different
amounts and the antibodies used in the kits are also the same. The only difference
between the kits is the amplification stage, which is present in the HS kit to
provide extra sensitivity (as referred to by R&D System). We made the analysis
using the QuantikineÔ kit  for the after exposure high value .
Our result showed that the best IL-1§ signal was obtained by use of the PBMC
method. The fresh PBMC, which gave the best signal after two cycles of freezing
(to create intercellular IL-1§ release), was used. The values detected by use of
chloroform extraction and poor-platelet plasma were identical (figure 20).
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5. Discussion
Inhalation of dust generated during the weighing of swine causes acute
inflammatory changes in the airways and systemic effects such as malaise and
fever. The condition is often called ODTS and is well known from other
environments such as in cotton cardrooms ("mill fever"), and in grain handling
("grain fever") (121, 122). The present study was focused on the proinflammatory
cytokines IL-1, IL-6 and TNF-a in this condition. The concentrations of these
acute phase cytokines were studied in airway and alveolar lining fluid and in
peripheral blood. and time course of appearance of the cytokines was studied in
blood, as well as the relationship with exposure and with local and general
symptoms. The role of endotoxin and other possible agents was studied both in
human exposure studies and in vitro, and finally the production of these cytokines
by alveolar macrophages and an epithelial cell line were compared after addition
of swine dust in vitro.
In order to ensure reliable results, several measures were taken. Blood was
collected using evacuated collecting tubes. Random and only selected tubes were
analysed for endotoxin, and all were negative. The same pairs of monoclonal
antibodies (R&D) were used throughout the studies. For some purposes an
amplified method was used, however, using the same monoclonal antibody.
Comparison of 30 samples analysed with the regular or the amplified method
show good correlation. Methods to measure IL-1§ were only available in the late
phase of the study. Three different methods were used. Analysis of chloroform
extracted plasma, analysis of platelet poor plasma  (123) and analysis of the
PBMC fraction isolated (89, 124) using density-grade centrifugation of blood.
Since clotting protein may inhibit IL-1§ (116, 118)., plasma was immediately
separated for use. The chloroform extraction method and the fresh platelet poor
plasma samples gave similar IL-1§ results, which however were below the
detection limit of the method in pre-exposure blood samples. The PBMC method
gave higher values, detectable also in pre-exposure blood.
In the present study the proinflammatory cytokines all increased in peripheral
blood, NAL and BAL fluid, with much higher concentrations in BAL than in
blood. The concentration of the cytokines correlated with exposure intensity and
with local and general effects such as increase in acute phase proteins (CRP,
orosomucoid and haptoglobin), a well known effect of  the acute phase cytokines
(125, 126). TNF-a, IL-6, IL-1§ and IL-1ra in peripheral blood increased in all
subjects. Peak levels of TNF-a and IL-6 were reached respectively at 4 (3-5) and
7 (4-9) hours after the start of the 3 h period of exposure. Although the TNF peak
always preceded maximal IL-6 values, there were signs of a smaller increase in
IL-6 that was parallel to the TNF-a change. There was a considerable variability
in the temporal relations between TNF-a and IL-6. Thus peak levels of TNF-a
preceded the maximum IL-6 level, in some cases by only one and half hour, and
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in others up to five hours (paper I). There was also an indication of a late phase of
IL-6 release following swine dust exposure in several subjects. There are several
sources that contribute to cytokine release following inhalation of swine dust.
Alveolar macrophages and epithelial cells have been induced to produce and
release cytokines (127). An early source might be release of pro-inflammatory
cytokines in airway mast cells (128), and possibly cells recruited to the airways
may contribute as late sources. TNF-a is a potent trigger for IL-6 release in vivo
and in vitro (129). The positive correlation of the maximum values of IL-6 and
TNF-a found in the present study are consistent with the observation that IL-6
can be induced by TNF-a. However, the apparent biphasic peaks of IL-6 and the
variable temporal relationship between the peak values of TNF-a   and IL-6
suggests that other mechanisms than TNF-a inducing IL-6 synthesis contribute to
the release of IL-6 as well.
IL-1ra reached peak level at 3-6 h and remained elevated at 24 h in
administration of LPS in rabbits (130). Our experimental results show that  IL-1ra
levels are higher at 7 h than at 4 h after the start of exposure. Time course studies
indicate that PBMC IL-1§ was elevated 3 h after exposure to swine dust, with
peak values after 4 to 7 h (paper IV). IL-1§ time curve was similar with the
kinetics observed for IL-1§ mRNA in purified monocytes and the whole blood
culture (103). From the whole blood culture it is known that IL-1§ mRNA was
present quite early after stimulation, peak levels were sustained at least 6 hours
after stimulation, and mRNA still existed at 18 h (131).
Inhaled swine dust also causes a release of the pro-inflammatory cytokines,
TNF-a, IL-6, IL-1-a and IL-1b in the upper and lower airways. There are many
cell types such as monocytes, macrophages, lymphocytes, fibroblasts, neutrophils,
epithelial and endothelial cells in the airways which are capable of IL-1
production (132). Both IL-1a and IL-1b could be produced by one cell type but
there are also cells which are specialized to produce IL-1 of one or the other type.
Thus monocytes/macrophages are the major sources for IL-1b (89, 133)(23) while
T cells are predominantly IL-1a producers (134). IL-6 is produced by epithelial
and endothelial cells, monocytes/ macrophages and lymphocytes (135). Alveolar
macrophages are the major source of TNF-a in the lower airways (136).
It is not clear which cells are responsible for the cytokine production in the
nose. Nasal epithelial cells may be one of the sources for IL-1 and TNF-a (127)
In the present study an clear increase neutrophils was found in nasal lavage fluid
following exposure. Other cells like macrophages, dendritic cells, lymphocytes
and mast cells  may also be of importance as sources of cytokines (137) in the
present study.
The pro-inflammatory cytokine family, including IL-1, TNF-a and IL-6, share
many overlapping biologic functions. High levels of IL-6 signals can contributes
to the inflammatory reaction and reflect the production of biologically active IL-1
and TNF (138, 139). TNF and IL-1 were important in the reaction of
inflammation and pathogenesis of airway disease. IL-1ra and IL-1 measurement
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can explain the symptoms, for example, fever, chill, myalgia, and malaise.
Elevated leukocyte count may increase serum cytokine concentrations, since
leukocytes are major secretors of cytokines (140).
Swine farmers have an increased number of cells and an increased proportion of
neutrophils in bronchoalveolar lavage fluid, indicating alveolitis (141). Similar
but more pronounced cellular changes in bronchoalveolar lavage fluid were
observed following exposure to dust in a swine confinement building also in
subjects not previously exposed to swine dust (142, 143). The present study
demonstrated a high levels of TNF-a and IL-1 in BAL and NAL These cytokines
act synergistically on the stimulation of polymorphonuclear neutrophilic
granulocyte migration (144) and stimulate vascular endothelial cells to promote
transendothelial passage of neutrophils, albumin, and fluid in vitro and in animal
experiments (145-147). TNF-a, IL-1 and LPS induce the expression of the
adhesion molecules ICAM-1, VCAM-1 and E-selectin on endothelial cells
promoting adhesion to granulocytes, monocytes and lymphocytes (148-150). The
production of TNF-a and IL-1 in the upper and lower airways could thus
contribute to the influx of inflammatory cells following exposure. We have also
found high levels of IL-8 in NAL and BAL (151). IL-8 is a potent  neutrophil
chemotactic and activating factor(152, 153).
Inhalation of swine dust caused a marked increase in bronchical responsiveness
(154). Our studies confirmed these results: post exposure PD 20 FEV1 were < 8%
of the pre-exposure value. The FEV1 decreased approximately 5 % and VC 2 %
in our studies. Pig-derived material, such as dander and faeces, some irritate gases
and TNF-a may contribute to increase bronchial responsiveness, as well as for
example mast cell products like cysteinyl leukotriene (155-157).
It is not clear which components in swine dust are responsible for the
inflammatory reaction. Air sampled from pig confinement building contains grain
dust, amonia, fungi and bacteria, mostly Gram positive but also Gram negative
(22). Lipopolysaccharide (LPS) from endotoxin in Gram negative bacteria is a
potent stimulus for cytokine production in alveolar macrophages and inhalation of
endotoxin induces airway inflammation with a cellular reaction dominated by
neutrophils (158) Although endotoxin could be responsible for the airway reaction
there are findings indicating that other components probably are of importance.
Studies in our laboratory have shown that swine dust is more potent than LPS in
stimulating the release of IL-6 and IL-8 from epithelial cells (159) while LPS
seems to be a more potent stimulus than swine dust inducing production of those
cytokines in alveolar macrophages
The first report on possible etiologic agents was published by Neal and co-
workers in 1942 (160). They studied fever among rural mattress workers and
provided good evidence that toxic agents from Gram-negative bacteria,
"endotoxin", could be a causative factor. Inhalation of endotoxin can reproduce
most of the symptoms of ODTS (161).
The present studies dust exposure was very high, above the Swedish threshold
limit value (5 mg/m3) for organic dust. The procedure of weighing pigs causes
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much agitation and results in the aerosolisation of dust from finely milled feed
and faecal products. The respirable fraction of the dust, measured with the
personal Cyclone sampler, constituted about 5 % of the inhalable dust fraction,
suggesting that a significant proportion of the dust may reach the alveoli.
However, measurement of BAL cytokines suggests considerable involvement also
of the peripheral airways. Dust deposited in the airways may interact with airway
epithelial cells, which are known to be important sources of inflammatory
cytokines, and may contribute to induce and sustain inflammatory reactions (95).
The swine faeces contains Gram-positive and Gram-negative bacteria both of
which contain peptidoglycans. Both Gram-positive and Gram-negative bacteria
contain soluble cytoplasmic components, which may induce cell activation in
vitro. Gram-positive bacterial cell walls contain many elements that may
influence airway cells, including peptidoglycans, teichuronic acid and formyl-
methionyl-leucyl-like peptides (fmlp) (162). The dose of inhaled endotoxin
required to cause ODTS appears to be much higher than the amount of endotoxin
inhaled in swine dust causing similar symptoms (163). In experiments where
aerosols of endotoxin or Gram-negative bacteria are inhaled, the endotoxin dose
must be in the order of 30-100 mg to produce symptoms. The aerosol size used in
these experiments favors alveolar deposition and interaction between endotoxin
and alveolar macrophages. In the present study, the average dose of inhaled
endotoxin was about 4 mg (assuming a ventilation of 1 m3) per hour. Even the
estimate for the total mass of inhalable LPS as calculated from the 3-OH fatty acid
content (about 16 mg) appears insufficient.
Endotoxin reflects Òbiological activityÓ of Lipopolysaccharides (LPS) in Gram-
negative bacteria and 3-OH fatty acids is a marker for total amount of LPS.
Muramic acid is a marker for peptidoglycans in cell walls of Gram-positive and
Gram-negative bacteria. In the present study, markers of microbial contaminants
present in mg-quantities possessed a stronger relationship with health effects than
did the mass of inhaled dust in mg-quantities. Most of the mass of inhaled dust is
probably made up by particles from finely milled barley, but numerous other
constituents are also present. One such component is bacteria from, for example,
swine faeces. These are both Gram-negative and Gram-positive, and probably
many are present as non-viable bacterial fragments. Preliminary data indicate that
the concentration of peptidoglycan in 9 bacterial strains (G- and G+) varied
between 0.25-6.4 % of the dry weight. The concentration of peptidoglycans in
swine dust samples varied between 0.01-0.23 % of the dry weight suggesting that
bacteria could make up about 4 % of the swine dust mass. Muramic acid is a
prominent component of Gram-positive bacteria, but is also present in Gram-
negative bacteria, although in lesser amounts. The present study suggests that
some of the health effects were related to mainly Gram-negative markers, while
other effects were correlated with muramic acid, but not with endotoxin or 3-OH
fatty acid. The correlation between exposure markers and health effects were
generally rather weak, which reduces the strength of the evidence. Still, the results
are more compatible with hypothesis that also other agents than LPS contribute to
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the health effects, rather than supporting an hypothesis that LPS is the sole
responsible agent. The data also suggests that different health effects may be
influenced by different components in the dust, rather than one agent causing all
effects.
Swine dust, but not LPS, induces a IL-6 release from an epithelial cell line
(A549). The cytokine concentrations in the cell culture supernatant increased in a
dose-effect manner. The surface epithelium plays an important role in the repair
of tissue damage inflicted by infection, inhaled particles and inflammation.
Secretions of cytokines have an important role to repair bronchial tissue damage.
The cytokine response to LPS for different epithelial cells difference. Most
carcinoma epithelial cells have no TNF-a production (164). A549 cell, derived
from alveolar epithelial cells of a cancer patient, has been used as a model system
for investigation of human alveolar epithelium.
We have found that both Gram-positive (Bacillus subtilis, Staphylococcus
hominis, S.Lentus, Micrococcus luteus ) and Gram-negative (E.coli) bacteria in
swine dust induce IL-8 (165) and IL-6 secretion in epithelial cells. Swine dust
contains different bacteria, both dead and cultivable. The cultivable flora is
dominated by Gram-positive bacteria (22). In a human exposure study, bacterial
markers showed better correlation with IL-6 changes in serum than did the
inhalable dust concentration. Markers for both G+ and G- bacteria (muramic acid
and 3-OH Fatty acids) correlated significantly with increase in serum IL-6 (166).
LPS is an abundant component of the outer membrane of Gram-negative
bacteria (167). LPS triggers the production of TNF-a, IL-1§, IL-6 and
granulocyte-macrophage colony-stimulating factor (GM-CSF) in monocytes,
endothelial cells (168-171) and alveolar macrophages (172). In the present study,
LPS was used as a reference agent. LPS did, however, not induce IL-6 release
from the A549 epithelial cell line used in the present study. The lack of a LPS-
induced effect on epithelial cells may be due to the absence of surface CD-14
receptor on these cells (173). In a previous study swine dust induced a 10-fold
greater IL-8 production in normal human bronchial epithelial cells in primary
culture compared with our A549 cell line. Thus the A549 epithelial cell line may
not be representative of human epithelial cells in all respects. It is, however,
interesting that swine dust was a powerful inducer of IL-6 in the A549 cell line.
The alveolar macrophage plays a central role in the defence against invading
microorganisms (174). Alveolar macrophage produces chemokines that recruit
neutrophils from the bloodstream. Alveolar macrophage releases IL-1, IL-6 and
TNF-a when cultured together with swine dust or LPS in the present study. It is
interesting to note that swine dust was almost equipotent on a weight basis
compared with LPS. Since the endotoxin concentration in the swine dust extract
was only 2.6 ng/100 mg, our findings cannot be explained by the endotoxin
content in the dust. This suggests that one or more very potent agents must be
present in the swine dust. These agents may be derived from bacteria or from
other components in the dust.
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6. Conclusions
¥ Healthy subjects who have no previous exposure to farm dust or swine dust
display elevated serum IL-6 and TNF-a levels, following 3 hours inhale swine of
dust.
¥ The IL-1 family participates in and modulates the inflammatory response
together with IL-6 and TNF-a.
¥ The levels of the blood cytokines change correlated with the systemic effects,
suggesting that the serum cytokine concentrations determined may explain the
transient fever, malaise, myalgia and other symptoms in ODTS.
¥ The exposure to swine dust causes an intense airway inflammation which
involves the pro-inflammatory cytokines IL-1, IL-6 and TNF-a  in
bronchoalveolar and nasal lavage.
¥ The serum IL-6 concentration correlates with exposure to the swine dust. The
changes in cytokines and inflammatory parameters correlated better with markers
of bacterial contaminants than with total dust.
¥ Both Gram-positive and Gram-negative bacteria may play a role in the induction
of airway inflammation and systemic health effects.
¥ Swine dust activates a cytokine response in epithelial cells and alveolar
macrophages. The epithelial cell has more limited cytokine response profile than
have alveolar macrophages. These two type cells may contribute to the lower
airways inflammatory reaction to swine dust.
¥ In the epithelial cell line swine dust was  a more potent stimulus for IL-6 release
than LPS.
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7. Summary
Zhiping Wang. Acute Cytokine Responses to Inhaled Swine Confinement
Building Dust. Arbete och Hlsa 1997; 23 1-61.
Inhalation of swine house dust (swine dust) may cause an acute inflammatory
reaction known as Organic Dust Toxic Syndrome (ODTS). The reaction does not
require sensitisation and is associated with airway inflammation, general
symptoms, and slight spirometric changes. The agents causing this reaction are
not known. The purpose of this study was to investigate the release of pro-
inflammatory cytokines in the airways and peripheral blood following acute
exposure to swine dust, the correlation between markers for microbial
contaminants in the dust, cytokine responses and health effects, and the release of
those cytokines from an epithelial cell line (EP) and from human alveolar
macrophages (AM) stimulated by swine dust and LPS.
Healthy subjects, previously unengaged in farm work were exposed to swine
dust for 3-4 hours. Interleukin (IL) -6, IL-1 receptor antagonist (ra) and tumour
necrosis factor (TNF)-a in serum, and IL-1§ in peripheral blood mononuclear cell
(PBMC) were measured prior to and after exposure. IL-1a, IL-1§, IL-6 and TNF-
a were also measured in nasal lavage (NAL) fluid and bronchoalveolar lavage
(BAL) before and after exposure. The time curves were done for IL-6, TNF-a and
IL-1§. The mass of inhaled dust, the endotoxin concentration and two markers
(muramic acid is a marker for total peptidoglycan content and 3-(OH)-fatty acid is
a marker for total lipopolysaccharide content) for microbial exposure were
quantified. Spirometry and a methacholine bronchial challenge were performed
before and 7 h after exposure to swine dust. Granulocytes, monocytes, and
lymphocytes were measured in blood with flow cytometry. NAL, BAL and
PBMC cells were measured with colour stain. The oral  temperature and general
symptoms were recorded.
Exposure to swine dust caused fever, headache, malaise, increased bronchial
responsiveness, and a slight decrease in FEV1 and VC. IL-1ra, IL-6 and TNF-a
increased significantly in serum, IL-1§ increased significantly in PBMC and
plasma, IL-1, IL-6 and TNF-a increased significantly in BAL and NAL fluids.
There was a marked influx of inflammatory cells, especially of granulocytes. In
peripheral blood, TNF-a, IL-6 and IL-1§ increased and peaked during 3-5 h,  5-7
h and 3-7 h respectively, after the start of exposure. The leukocytes doubled and
monocytes increased slightly 6-8 h after exposure. Endotoxin, muramic acid, and
3-OH fatty acid correlated significantly with increase in serum IL-6. Inhalable
dust correlated with increase in serum IL-1ra, and endotoxin correlated with
increase IL-1§ in PBMC. Endotoxin and 3-OH fatty acids also correlated
significantly with the IL-6 increase in BAL. Bacterial markers showed better
correlation with IL-6 changes than with total dust concentrations. LPS correlated
with symptoms and with lung function changes. Peptidoglycan correlated with
increase in blood granulocytes and body temperature.
Swine dust caused a dose-dependent increase of IL-1§, IL-6 and TNF-a in AM.
No increase of IL-1§ or TNF-a, but a clear increase in IL-6 was found in EP. LPS
caused a clear increase in all three cytokines in AM, but none of the cytokines in
EP.
In conclusion, acute inhalation of dust contaminated with bacterial debris
increased the concentration of pro-inflammatory cytokines in BAL, NAL, PBMC
and peripheral blood. The changes in cytokines and inflammatory parameters
correlated better with markers of bacterial contaminants than with total dust
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amounts. A marker for bacterial peptidoglycan showed better correlation with
some changes than endotoxin did, suggesting that several bacterial constituents
may play a role in ODTS. The results of in vitro tests suggest that swine dust
activated a cytokine response in EP and AM. The EP had more a limited cytokine
response profile than AM. In EP, swine dust is a more potent stimulus for
cytokine release than LPS. Both cells can contribute to inflammatory reaction
after inhalation of swine dust, and several agents including LPS may play an
important role in cytokine release.
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8. Sammanfattning (Summary in Swedish)
Zhiping Wang. Akuta cytokinreaktioner efter inandning av damm frn svinhus.
Arbete och Hlsa 1997;23 1-63.
Inandning av svinhusdamm (svindamm) kan ge upphov till en akut
inflammatorisk reaktion i form av allergisk alveolit och feberattacker(Organic
Dust Toxic Syndrome, ODTS). Reaktionen frknippas med luftvgsinflammation,
allmnna symptom och ltta spirometriska frndringar och krver ingen
fregende sensibilisering fr att upptrda. Vilka mnen som orsakar reaktionen
r inte knt. Syftet med underskningen var att underska fristtandet av
inflammatoriska cytokiner i luftvgar och perifert blod som en fljd av akut
exponering fr svindamm, korrelationen mellan markrer fr kontaminanter i
mikrobiellt damm, cytokinreaktion och hlsoeffekter, samt cytokinfristtningen
frn en epitel cellinje (EP) och mnskliga alveolra makrofager (AM) som
stimulerats av svindamm och LPS.
Friska frskspersoner utan tidigare erfarenhet av arbete med djur exponerades
fr svindamm under 3 - 4 timmar. Fre och efter exponeringen uppmttes
interleukin (IL) -6, receptorantagonist IL-1 (ra), nekrosfaktorn fr tumrer (TNF)
-a i serum, samt IL-1§ i mononuklera celler frn perifert blod (PBMC). ven IL-
1a, IL-1§, IL-6 och TNF-a uppmttes i nasalt lavage (NAL) och bronkoalveolrt
lavage (BAL) fre och efter exponeringen. Tidskurvorna utfrdes fr IL-6, TNF-
a och IL-1§. Massan fr det inhalerade dammet bestmdes, samt endotoxin
koncentrationen och tv markrer fr mikrobexponeringen (muraminsyra, som r
en markr fr totalinnehllet av peptidoglykan, och 3-(OH)-fettsyra, som r en
markr fr totalinnehllet av lipopolysackarider). Fre exponeringen fr
svindammet, och 7 timmar efter, utfrdes spirometri och en bronkial
metakolintest. Granulocyter, monocyter och lymfocyter uppmttes i blodet med
fldescytometri. NAL-, BAL- och PBMC-cellerna uppmttes med hjlp av
frgning. Orala temperaturer och allmnna symptom antecknades.
Exponering fr svindamm orsakade feber, huvudvrk, ltt illamende, frhjd
bronkiell reaktivitet samt en liten minskning av FEV1 och VC. IL-1ra, IL-6 och
TNF-a kade signifikant i serum, IL-1§ kade signifikant i PBMC och plasma,
och IL-1, IL-6 och TNF-a kade signifikant i BAL- och NAL-vtskor. Det fanns
ett markant inflde av inflammatoriska celler, i synnerhet granulocyter. TNF-a,
IL-6 och IL-1§ kade och ndde toppvrden i perifert blod inom loppet av 3-5
tim, 5-7 tim respektive 3-7 tim efter exponeringens brjan. Antalet leukocyter
frdubblades och en mttlig kning av antalet monocyter intrffade 6-8 tim efter
exponeringen. Endotoxin, muraminsyra och 3-OH-fettsyra korrelerade signifikant
med kningen av serum IL-6. Respirabelt damm korrelerade med kningen av
serum IL-1ra och endotoxin korrelerade med kningen fr IL-1§  i PBMC.
Endotoxin och 3-OH-fettsyror korrelerade ocks signifikant med kningen av IL-
50
6 i BAL. Bakteriella markrer visade bttre korrelation med frndringar fr IL-6
n med totala dammkoncentrationer. LPS korrelerade med symptom och
frndrade lungfunktioner. Peptidoglykan korrelerade med en kning av
blodgranulocyterna och kroppstemperaturen.
Svindamm orsakade dosberoende kningar av IL-1§, IL-6 och TNF-a i AM.
Ingen kning av IL-1§ eller TNF-a frekom, men en tydlig kning av IL-6
konstaterades i EP. LPS orsakade en tydlig kning av samtliga tre cytokineri AM,
men inte fr ngon av cytokinerna i EP.
Sammanfattningsvis kan sgas att akut inandning av bakteriellt frorenat damm
kade koncentrationen av inflammatoriska cytokiner i BAL, NAL, PBMC och
perifert blod. ndringar av cytokiner och inflammatoriska parametrar korrelerade
bttre med markrer fr bakteriella kontaminanter n med total dammngd. En
markr fr bakteriell peptidoglykan uppvisade bttre korrelation med vissa
frndringar n vad endotoxin gjorde, vilket ger anledning frmoda att flera
bakteriella komponenter kan ha betydelse fr ODTS. Resultaten av in vitro-
testerna talar fr att svindamm aktiverade en cytokin respons i EP och AM. EP
hade en mer begrnsad cytokin responsprofil n AM. I EP r svindamm en mer
potent stimulant fr cytokinfristtning n LPS. Bda cellerna kan bidra till
inflammatoriska reaktioner efter inandning av svindamm, och flera av mnena -
inklusive LPS - kan vara viktiga faktorer fr cytokinfristtningen.
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